Form D — Senti Biosciences Holdings, Inc.
0001193125-26-256064 · filed Jun 4, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $40,000,000
- Total sold
- $10,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Senti Biosciences Holdings, Inc.
- CIK
- 1854270
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2 Corporate Drive, First Floor
South San Francisco, CA 94080 - Phone
- 650-239-2030
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Timothy Lu · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Edward Mathers · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Frances D. Schulz · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Donald Tang · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Brenda Cooperstone · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
James J. Collins · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Feng Hsiung · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Bryan Baum · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Jay Cross · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Kanya Rajangam · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗